New Biomarker Enables Early and Accurate Parkinson's Diagnosis

New body-fluid biomarker for Parkinson's disease discovered

Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.

Family shares personal journey to inspire others and support Parkinson's research

Nearly one million people in the U.S. are living with Parkinson's disease, with approximately 90,000 new diagnoses each year. In recognition of April as Parkinsons Awareness Month, an event is happening this weekend to raise awareness about the significance of movement and the ongoing research needed to combat this progressive disease.The Marrs family shares a personal connection to Parkinsons disease. Richard Marrs opened up about the diagnosis…

New biomarker offers hope for early Parkinson’s diagnosis

A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson’s disease in body fluids.

Spinal fluid biomarker offers early and accurate Parkinson's disease diagnosis

Parkinson's disease is a neurodegenerative disorder that is usually diagnosed in its late stage on the basis of clinical symptoms, mainly motor disorders. By this point, however, the brain is already severely and irreparably damaged. Moreover, diagnosis is difficult and often incorrect because the disease takes many forms, and symptoms overlap with other disorders.

They discover a new biomarker from Parkinson’s disease in body fluids

Researchers at the PRODI Protein Diagnosis Center at the University of Ruhr in Bochum (Germany) and the biotechnological company betaSENSE have discovered a biomarker in cerebrospinal fluid that facilitates a reliable diagnosis at an early stage of Parkinson’s disease and can shed light on its progression and the effect of a therapy.